- Home
- KYMR vs TAC Comparison
KYMR vs TAC Comparison
Compare KYMR & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- TAC
- Stock Information
- Founded
- KYMR 2015
- TAC 1909
- Country
- KYMR United States
- TAC Canada
- Employees
- KYMR N/A
- TAC N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- TAC Electric Utilities: Central
- Sector
- KYMR Health Care
- TAC Utilities
- Exchange
- KYMR Nasdaq
- TAC Nasdaq
- Market Cap
- KYMR 4.3B
- TAC 5.1B
- IPO Year
- KYMR 2020
- TAC N/A
- Fundamental
- Price
- KYMR $59.94
- TAC $16.86
- Analyst Decision
- KYMR Strong Buy
- TAC Strong Buy
- Analyst Count
- KYMR 19
- TAC 4
- Target Price
- KYMR $66.84
- TAC $21.63
- AVG Volume (30 Days)
- KYMR 631.1K
- TAC 2.4M
- Earning Date
- KYMR 11-04-2025
- TAC 11-06-2025
- Dividend Yield
- KYMR N/A
- TAC 1.07%
- EPS Growth
- KYMR N/A
- TAC N/A
- EPS
- KYMR N/A
- TAC N/A
- Revenue
- KYMR $43,735,000.00
- TAC $1,838,165,207.00
- Revenue This Year
- KYMR $60.88
- TAC N/A
- Revenue Next Year
- KYMR N/A
- TAC N/A
- P/E Ratio
- KYMR N/A
- TAC N/A
- Revenue Growth
- KYMR N/A
- TAC N/A
- 52 Week Low
- KYMR $19.45
- TAC $7.82
- 52 Week High
- KYMR $63.96
- TAC $17.88
- Technical
- Relative Strength Index (RSI)
- KYMR 55.80
- TAC 58.00
- Support Level
- KYMR $55.66
- TAC $16.55
- Resistance Level
- KYMR $63.36
- TAC $17.82
- Average True Range (ATR)
- KYMR 3.07
- TAC 0.58
- MACD
- KYMR -0.37
- TAC -0.15
- Stochastic Oscillator
- KYMR 57.78
- TAC 40.11
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.